Clark Capital Management Group’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-5,200
Closed -$290K – 337
2016
Q2
$290K Hold
5,200
– – 0.02% 263
2016
Q1
$316K Hold
5,200
– – 0.02% 265
2015
Q4
$332K Hold
5,200
– – 0.03% 254
2015
Q3
$348K Hold
5,200
– – 0.03% 242
2015
Q2
$355K Hold
5,200
– – 0.03% 248
2015
Q1
$289K Hold
5,200
– – 0.03% 272
2014
Q4
$267K Buy
+5,200
New +$255K 0.02% 266
2014
Q3
– Sell
-5,200
Closed -$203K – 336
2014
Q2
$203K Buy
+5,200
New +$193K 0.02% 310
2014
Q1
– Sell
-10,982
Closed -$415K – 378
2013
Q4
$415K Sell
10,982
-5,346
-33% -$205K 0.03% 216
2013
Q3
$709K Sell
16,328
-34
-0.2% -$1.36K 0.06% 155
2013
Q2
$592K Buy
+16,362
New +$497K 0.05% 167

Other funds holding USNA

Clark Capital Management Group's USNA Position: Q3 2016 in Review

Clark Capital Management Group sold out of Usana Health Sciences (USNA) in Q3 2016, closing a stake of 5,200 shares — an estimated $290K sold.

Clark Capital Management Group first reported a position in USNA in Q2 2013 and held it in 11 quarters. The position peaked at $709K in Q3 2013. 140 funds tracked by Wall St. Rank hold USNA as of Q3 2016.

  • Clark Capital Management Group reported no remaining Usana Health Sciences position as of Q3 2016 after selling out during the quarter.
  • Clark Capital Management Group sold 5,200 Usana Health Sciences shares in Q3 2016, an estimated $290K.
  • Clark Capital Management Group first reported a position in Usana Health Sciences in Q2 2013 and held it in 11 quarters.
  • Clark Capital Management Group's Usana Health Sciences position peaked at $709K in Q3 2013.
  • 140 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2016.

Based on Clark Capital Management Group's 13F filing for Q3 2016, filed 14 Nov 2016.